The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Brenner Randall B. since 2019.
This trader's CIK number is 1788249.
At the time of last reporting, Brenner Randall B. was the Chief Development & Regulatory of Paratek Pharmaceuticals, Inc.. (stock ticker symbol PRTK).
Also see all insider trading activities at Paratek Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | PRTK | 0 | $0 | 27,603 | $60,726 | 0 | $0 |
| 2022 | PRTK | 0 | $0 | 48,890 | $109,770 | 0 | $0 |
| 2021 | PRTK | 0 | $0 | 46,638 | $262,208 | 0 | $0 |
| 2020 | PRTK | 0 | $0 | 29,479 | $180,615 | 0 | $0 |
| 2019 | PRTK | 0 | $0 | 19,001 | $69,290 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-09 | PRTK | Sale | 27,603 | 2.20 | 60,726 |
| 2022-12-12 | PRTK | Sale | 11,105 | 1.98 | 21,987 |
| 2022-12-13 | PRTK | Sale | 18,177 | 1.96 | 35,626 |
| 2022-08-09 | PRTK | Sale | 19,608 | 2.66 | 52,157 |
| 2021-12-13 | PRTK | Sale | 4,479 | 4.42 | 19,797 |
| 2021-12-14 | PRTK | Sale | 7,635 | 4.37 | 33,364 |
| 2021-12-15 | PRTK | Sale | 15,780 | 4.27 | 67,380 |
| 2021-08-17 | PRTK | Sale | 8,766 | 5.12 | 44,881 |
| 2021-06-04 | PRTK | Sale | 9,978 | 9.70 | 96,786 |
| 2020-12-11 | PRTK | Sale | 6,164 | 6.95 | 42,839 |
| 2020-12-14 | PRTK | Sale | 8,760 | 6.71 | 58,779 |
| 2020-11-13 | PRTK | Sale | 8,357 | 5.93 | 49,557 |
| 2020-05-12 | PRTK | Sale | 6,198 | 4.75 | 29,440 |
| 2019-12-12 | PRTK | Sale | 6,278 | 3.10 | 19,461 |
| 2019-10-08 | PRTK | Sale | 5,049 | 3.82 | 19,287 |
| 2019-10-03 | PRTK | Sale | 7,674 | 3.98 | 30,542 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brenner Randall B. (Chief Development & Regulatory of Paratek Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.